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ABSTRACT
The new synthetic geranyl-2,4-methoxyhydroquinone 1 and the known geranyl-4,5-methoxyhydroquinone 2 were prepared by Electrophilic Aromatic 
Substitution (EAS) reactions between geraniol and 1,3,5-trimethoxyphenol using BF3∙Et2O as a catalyst. Furthermore, the new geranylmethoxyhydroquinones 
derivatives (3-6) were obtained by chemical transformations of 1 and 2. The compounds have been evaluated for their cytotoxic activities against PC-3 human 
prostate cancer cell line, MCF-7 and MDA-MB-231 human breast cancer cells lines and dermal human fibroblasts DHF. IC50 values for compounds 1 and 5 ranged 
in the 80 µM level.
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INTRODUCTION
Polyprenylated 1,4-benzoquinones and hydroquinones such as 
ubiquinones, plastoquinones, and tocopherols are widespread in plants 
and animals, in which they play important roles in electron transport, 
photosynthesis, and as antioxidants1,2. Prenyl benzoquinones have been also 
isolated from brown algae of the order Fucales3-6, sponges7-10, alcyonaceans11, 
gorgonaceans12, and ascidians belonging to the genus Aplidium13-18. These 
substances present a terpenoid portion ranging from one to nine isoprene units. 
On the other hand, different studies of the structure activity relation (SAR) in 
a series of nonmethoxylated and methoxylated prenylated quinones with side 
chains containing from one to eight isoprene units reported that the optimum 
length of the side-chain is two isoprene units and in the para-position relative 
to the methoxy-group19, 20. Additionally, these authors informed that all tested 
quinones (3-Demethylubiquinone Q2 and its synthetic derivatives) have 
inhibited of JB6 Cl41 cell transformation and p53 activity and induction of 
apoptosis, AP-1 and NF-kB activity.
Due to the importance that showed by these compounds in the mentioned 
biological activities, in this work we describe the synthesis and cytotoxic 
activity of geranylmethoxyhidroquinones derivatives (1-6). The new 
synthetic geranyl-2,4-dimethoxyhydroquinone 1 and known geranyl-4,5-
dimethoxyhydroquinone 2 were synthesized using the strategy of Electrophilic 
Aromatic Substitution (EAS) reactions, according to the reported protocol21-23. 
The geranylmethoxyhidroquinones derivatives (3-6) are synthetic analogs of 1 
and 2, while the known compound 5 is analogous to the marine natural product 
verapliquinone A. All the compounds were evaluated in vitro against various 
human cancer cells lines in order to analyse the influence of the molecular 
structure on the cytotoxic activity.
Scheme 1. Synthesis of 2,4,5-trimethoxyphenol 9 (a) MCPBA/CH2Cl2, r.t. 
1.87 g, 86%; (b) CH3OH/Et3N, r.t. 2.45 g, 78%.
The next objective consisted in the coupling reaction between geraniol 
with 2,4,5-trimethoxyphenol (9). For this purpose the strategy of Electrophilic 
Aromatic Substitution (EAS), was used21-23. Nevertheless, in this reaction 
was not possible to obtain the wished compound 10 (scheme 2) and 
unexpectedly two compounds were obtained: 2,4-dimethoxy-5-((E)-3’,7’-
dimethylocta-2’,6’-dienyl)phenol (1) (15% yield) and 4,5-dimethoxy-2-((E)-
3’,7’-dimethylocta-2’,6’-dienyl)phenol (2) (13% yield). The mass difference 
corresponds to geraniol not reacted, geraniol decomposition and not reacted 
2,4,5-trimethoxyphenol.
Figure 1. Structure of synthesized compounds.
RESULTS AND DISCUSSION
Chemistry
Our first objective was the preparation of compound (9) from commercially 
available asaronaldehyde (7). The first step involves a Baeyer Villiger 
oxidation reaction and subsequent saponification of formate 824, according to 
the synthetic route shown in scheme 1.
Scheme 2. Synthesis of geranylmethoxyhydroquinone derivatives. (a) 
dioxane/BF3∙Et2O, N2, r.t.: 1, 79.1 mg 15% and 2 65.3 mg 13% yield.
The formation of compounds 1 and 2 was not possible to explain it by the 
EAS strategy, probably the coupling reaction ocurred from a different pathway, 
competing with the EAS. In the presence of BF3, the compound 9 afforded 
the allyl aryl ethers 9a wich presumably undergoes Claisen rearrangement27-28 
giving the dienones 9b y 9c. The dienones recover the aromaticity through the 
formation and later loss of a formaldehyde molecule. The mechanism which 
was proposed to explain the formation of compounds 1 and 2 is showed in 
scheme 3.
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Scheme 3. Proposed reaction mechanism for the formation of compounds 1 and 2.
In the 1H-NMR spectrum of geranyl-2,4-dimethoxyphenol 1 the signals at 
δ 3.82 ppm (s, 3H, OCH3), 3.76 (s, 3H, OCH3) of the two methoxyl groups, δ 
3.25 ppm (d, J = 7.0, 2H, H-1’) of the point of coupling, 5.49 ppm (s, 1H, OH) 
of the phenol and two aromatic hydrogens at δ 6.68 ppm (s, 1H, H-6), 6.54 (s, 
1H, H-3) were mainly observed. In the 13C-NMR spectrum the presence of the 
methoxyl groups at δ 56.8 ppm, 56.1 ppm, the signals of two aromatic carbons 
at δ 99.3 ppm (C-3) and 112.8 ppm (C-6) also were confirmed. These data also 
were corroborated by 2D HMBC 3J heteronuclear correlations between H-1’ 
and the carbon signals at δ 151.8 (C-4), 112.8 (C-6), 136.0 (C-3’) ppm and 
2J with δ 122.8 (C-2’), 120.9 (C-5) ppm (figure 2a). The E-geometry of the 
trisubstituted C2’-C3’ double bond was established from gs-sel-1H 1D-NOESY 
experiments (figure 2b), where H-1’ showed a long range interaction with the 
methyl group in position 10’ (1.70 ppm). In addition, the configuration of the 
C2’-C3’ double bond was compared with the chemical shifts of C-10’ reported 
for similar compounds19.
Figure 2. Structure of compound 1. (a) HMBC correlations; (b) NOE 
correlations.
Nevertheless the 1H-NMR spectrum of 2 was compared with the reported 
spectral data20. This compound showed the existence of an hydroxyl group at 
δ 4.93 ppm and the presence of two aromatic hydrogens at δ 6.62 ppm (s, 1H, 
H-5); 6.45 ppm (s, 1H, H-6). In addition, the point of coupling was confirmed 
by the presence of the signal at δ 3.30 (d, J = 7.0 Hz, 2H, H-1’). While in the 
13C-NMR spectrum the signals at δ 113.7 (C-3), 101.2 (C-6) of two aromatic 
carbons and 29.6 (C-1’) corroborate the molecular structure.
For the preparation of 2,4-dimethoxy-5-((E)-3’,7’-dimethylocta-2’,6’-
dienyl)phenyl acetate derivative 3, the geranyl-2,4-dimethoxyphenol 1 was 
acetylated with acetic anhydride and dimethylaminopyridine (DMAP) as 
catalyst, then the compound 3 was obtained with a 55% of yield (scheme 4). 
The molecular structure was corroborated for the signals at δ 2.31 ppm, 20.7 
ppm, 169.2 ppm of the acetyl group, in addition for comparison of their spectral 
data with geranyl-2,4-dimethoxyphenol 1.
The preparation of 2,4,5-trimethoxy-1-((E)-3’,7’-dimethylocta-2’,6’-
dienyl)benzene derivative 4, was carried out by reaction of methylation with 
(CH3)2SO4 in slightly basic conditions of the compound 1 or 2 with a 40 % 
yield (scheme 4). 1H-NMR spectrum showed three singlets at δ 3.87 ppm 3.82 
ppm and 3.80 ppm, the signals corresponding to the methoxyl groups. These 
signals also were observed in the 13C-NMR spectrum at δ 56.3 ppm, 56.7 ppm 
and 56.6 ppm.
The 2-methoxy-5-((E)-3’,7’-dimethylocta-2’,6’-dienyl)-1,4-benzoqui-
none compound 5, was prepared by oxidation reaction of geranyl-4,5-dimeth-
oxyphenol 2 with nitrate of cerium and ammonium (CAN), and was obtained 
with a 15 % yield (scheme 4). The molecular structure was confirmed for the 
presence of the signals at δ 6.46 ppm (t, 1H, H-6) and 5.92 ppm (s, 1H, H-3) 
of the quinonic hydrogens in the 1H-NMR spectrum and the existence in the 
13C-NMR spectrum of two carbonyl carbons at δ 182.4 ppm (C-1), 187.6 ppm 
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(C-4), in addition to comparison with the spectral data reported for the com-
pound20.
Finally the 4,5-dimethoxy-2-((E)-3’,7’-dimethylocta-2’,6’-dienyl)phenyl 
acetate derivative 6, was prepared using the same protocol of synthesis for 
the derivative 3 with a 70 % yield (scheme 4). 1H-NMR and 13C-NMR spectra 
showed the signals corresponding to the acetyl groups at δ 2.29 ppm, 20.8 ppm 
and 169.8 ppm.
gel (Merck 200-300 mesh) was used for C.C. and silica gel plates HF-254 for 
TLC. TLC spots were detected by heating after spraying with 25% H2SO4 in 
H2O.
Chemistry
General procedure for the Electrophilic Aromatic Substitution (EAS), 
synthesis of compounds 1, 2
BF3.Et2O (0.08 g, 0.6 mmol) was gradually added at room temperature to 
a solution of 2,4,5-trimethoxyphenol (0.3278 g, 1.8 mmol) and geraniol (0.3 g, 
1.8 mmol) in freshly distilled 1,4-dioxane (20 mL). The mixture was stirred at 
room temperature under a nitrogen atmosphere for 24 h, when the completion 
of the reaction was verified by TLC. The mixture was poured onto crushed ice 
(about 30 g) and the organic layer was extracted with EtOAc (3 × 30 mL). The 
combined organic phase was washed with 5% NaHCO3 (30 mL), then with 
water (2 × 20 mL) and dried over anhydrous Na2SO4, filtered and evaporated. 
The crude residue was redissolved in CH2Cl2 (5 mL) and chromatographed 
on silica gel with petroleum ether/EtOAc mixtures of increasing polarity 
(19.8:0.2→16.0:4.0 for 1 and 19.8:0.2→13.0:7.0 for 2).
2,4-dimethoxy-5-((E)-3’,7’-dimethylocta-2’,6’-dienyl)phenol 1: colorless 
viscous oil, 79.1 mg (15%). 1H-NMR: 6.68 (s, 1H, H-6); 6.54 (s, 1H, H-3); 
5.49 (s, 1H, OH); 5.28 (t, J= 7.0 Hz, 1H, H-2’); 5.11 (t, J= 7.0 Hz, 1H, H-6’); 
3.82 (s, 3H, OCH3); 3.76 (s, 3H, OCH3); 3.25 (d, J= 7.0, 2H, H-1’); 2.08 (m, 
4H, H-5’ and H-4’); 1.70 (s, 3H, H-10’); 1.67 (s, 3H, H-8’); 1.60 (s, 3H, H-9’). 
13C-NMR: 144.1 (C-1), 140.1 (C-2), 99.3 (C-3), 151.8 (C-4), 120.9 (C-5), 
112.8 (C-6), 56.8 (OCH3), 56.1 (OCH3), 27.7 (C-1’), 122.8 (C-2’), 136.0 (C-
3’), 39.8 (C-4’), 26.8 (C-5’), 124.3 (C-6’), 131.4 (C-7’), 25.7 (C-8’), 17.7 (C-
9’), 16.1 (C-10’). IR (cm-1): 2924, 1602, 1512, 1194, 1042. MS (m/z, %): M+ 
290 (< 1%), 288 (13), 287 (28), 246 (43), 245 (9), 219 (12), 203 (15), 178 (39), 
177 (70), 175 (9), 163 (17), 161 (31), 149 (10) 124 (16), 123 (100), 122 (21), 
69 (36).
4,5-dimethoxy-2-((E)-3’,7’-dimethylocta-2’,6’-dienyl)phenol 2: colorless 
viscous oil, 65.3 mg (13%). 1H-NMR: 6.62 (s, 1H, H-5); 6.45 (s, 1H, H-6); 
5.30 (t, J= 7.0 Hz, 1H, H-2’); 5.07 (t, J= 7.0 Hz, 1H, H-6’); 4.93 (s, 1H, OH); 
3.82 (s, 6H, OCH3); 3.30 (d, J= 7.0, 2H, H-1’); 2.09 (m, 4H, H-5’ and H-4’); 
1.78 (s, 3H, H-10’); 1.68 (s, 3H, H-8’); 1.60 (s, 3H, H-9’). 13C-NMR: 148.4 
(C-1), 117.3 (C-2), 113.7 (C-3), 142.8 (C-4), 148.3 (C-5), 101.2 (C-6), 55.9 
(OCH3), 56.6 (OCH3), 29.6 (C-1’), 121.9 (C-2’), 138.6 (C-3’), 39.6 (C-4’), 26.4 
(C-5’), 123.7 (C-6’), 132.0 (C-7’), 25.6 (C-8’), 17.7 (C-9’), 16.2 (C-10’). IR 
(cm-1): 2924, 1619, 1512, 1451, 1195. MS (m/z, %): M+ 290 (40), 221 (4), 207 
(4), 205 (15), 190 (5), 175 (6), 168 (12), 167 (100), 166 (8), 69 (9).
Synthesis of geranylmethoxyhidroquinones derivatives (3–6)
2,4-dimethoxy-5-((E)-3’,7’-dimethylocta-2’,6’-dienyl)phenyl acetate 3
To geranyl-2,4-dimethoxyphenol 1 (0.0485 g, 0.16 mmol) dissolved in 
dichloromethane (10 mL), acetic anhydride (0.02 g, 0.02 mL, 0.16 mmol) and 
dimethylaminopyridine (DMAP, 2 mg, 0.016 mmol) were added. The mixture 
was stirred at room temperature during 2 hours. The organic phase was washed 
with water and after it was dried over anhydrous Na2SO4. The solution was 
evaporated to dryness to afford the crude reaction product, which gave 30 mg 
(55 % yield) of compound 3 after column chromatography (eluent to hexane/
ethyl acetate 19.8:0.2→17.8:2.2), colorless viscous oil. 1H-NMR: 6.80 (s, 1H, 
H-6); 6.57 (s, 1H, H-3); 5.30 (t, J= 7.0 Hz, 1H, H-2’); 5.12 (t, J= 7.0 Hz, 1H, 
H-6’); 3.77 (s, 3H, OCH3); 3.76 (s, 3H, OCH3); 3.30 (d, J= 7.0, 2H, H-1’); 2.31 
(s, 3H, CO2CH3); 2.09 (m, 4H, H-5’ and H-4’); 1.70 (s, 3H, H-10’); 1.67 (s, 
3H, H-8’); 1.60 (s, 3H, H-9’). 13C-NMR: 144.6 (C-1), 137.7 (C-2), 106.1 (C-3), 
151.2 (C-4), 128.2 (C-5), 114.4 (C-6), 56.0 (OCH3), 56.6 (OCH3), 28.0 (C-1’), 
122.0 (C-2’), 136.6 (C-3’), 39.7 (C-4’), 26.7 (C-5’), 124.2 (C-6’), 131.4 (C-7’), 
26.7 (C-8’), 17.7 (C-9’), 16.1 (C-10’); 20.7 (CO2CH3); 169.2 (CO2). IR (cm-1): 
2929, 1768, 1768, 1510, 1215, 1203, 1040. MS (m/z, %): M+ 332 (87), 291 
(20), 290 (94), 221 (39), 207 (16), 189 (40), 175 (18), 168 (14), 167 (100), 161 
(52), 154 (13), 129 (20), 69 (18).
2,4,5-trimethoxy-1-((E)-3’,7’-dimethylocta-2’,6’-dienyl)benzene 4
To 1 or 2 (90 mg, 0.3 mmol) dissolved in acetone (10 mL), potassium of 
carbonate (0.04 g, 0.3 mmol) and dimethyl sulphate (0.04 g, 0.3 mmol) were 
added. The mixture was stirred at room temperature during 24 hours. After 
Scheme 4. Synthesis of geranylmethoxyhydroquinone derivatives. 
(a) Ac2O/CH2Cl2/DMAP, r.t. for 3, 30 mg 55%; for 6, 30 mg 70% yield 
(b) (CH3)2SO4/K2CO3, acetone, r.t. for 4 from 1, 37 mg, 40% whereas for 
compound 4 from 2 the same yield was obtained (c) CAN/acetonitrile/water, 
r.t. 20 mg 15% yield. 
Antiproliferative activity
The cytotoxicity of the compounds was evaluated in vitro against three 
different cancer cell lines: PC-3 human prostate cancer, MCF-7 and MDA-
MB-231 human breast cancer and one non-tumoral cell line, dermal human 
fibroblasts (DHF) by using sulforhodamine dye assay. This conventional 
colorimetric assay was set up to estimate the IC50 values which represents the 
concentration of a drug that is required for 50% inhibition in vitro after 72 h 
of treatment with the test compounds. Five serial dilutions (from 12.5 to 100 
µM) for each sample were evaluated in triplicate. The results obtained from 
these assays are shown in Table 1. The compounds 2-4 and 6 did not affect 
the viability of the cells lines studied, however the compounds 1 and 5 showed 
IC50 values with inhibitory activity, ranged in the 80 µM level for breast cancer 
cell line MCF-7. Moreover the compound 5 showed IC50 values with inhibitory 
activity, ranged in the 80 µM level for breast cancer cell line MDA-MB-231, 
these values may be due to the presence of a quinone moiety. In the case of 
the compound 1 the cytotoxicity could be influenced by the position of the 
hydroxyl group in the ring, orto to the methoxyl group. Furthermore, it was 
demonstrated by the results obtained for the acetylated derivative 3 and the 
meta position of the hydroxyl group in the compound 2, which did not display 
cytotoxic activity. Moreover, compound 1 and 5 showed some selectivity for 
the cancer cells versus fibroblast cells because the IC50 for human fibroblast 
were on 100 µM, which could provide an approach to obtain compounds 
with potential less toxicity in normal human cells. The increased citotoxicity 
induced by compounds 1 and 5 on human breast cancer cell lines was due 
probably to the presence of a quinone moiety and orto position of the hydroxyl 
group on the structure of these compounds versus the compounds 2, 3, 4 and 6.
EXPERIMENTAL
General
Unless otherwise stated, all chemical reagents purchased (Merck or 
Aldrich) were of the highest commercially available purity and were used 
without previous purification. IR spectra were recorded as thin films in a 
Nicolet Impact 420 spectrometer and frequencies are reported in cm-1. Low 
resolution mass spectra were recorded on a Shimadzu QP-2000 spectrometer at 
70eV ionising voltage and are given as m/z (% rel. int.). 1H, 13C (DEPT 135), 
sel. 1D 1H NOESY, 2D HSQC and 2D HMBC spectra were recorded in CDCl3 
solutions and are referenced to the residual peaks of CHCl3 at δ 7.26 ppm and 
δ 77.0 ppm for 1H and 13C, respectively, on a Bruker Avance 400 Digital NMR 
spectrometer, operating at 400.1 MHz for 1H and 100.6 MHz for 13C. Chemical 
shifts are reported in δ ppm and coupling constants (J) are given in Hz. Silica 
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filtration, the solution was evaporated to dryness. Dilution with diethyl ether 
was followed by washing with NaOH solution (5%) and the organic phase was 
dried over anhydrous Na2SO4. The solution was evaporated to dryness to afford 
the crude reaction product, which gave 37 mg (40 % yield) of compound 4 after 
column chromatography (eluent to hexane/ethyl acetate 19.8:0.2→18.2:1.8), 
colorless viscous oil. 1H-NMR: 6.71 (s, 1H, H-6); 6.52 (s, 1H, H-3); 5.29 (t, 
J= 7.0 Hz, 1H, H-2’); 5.11 (t, J= 7.0 Hz, 1H, H-6’); 3.87 (s, 3H, OCH3); 3.82 
(s, 3H, OCH3); 3.80 (s, 3H, OCH3); 3.27 (d, J= 7.0, 2H, H-1’); 2.08 (m, 4H, 
H-5’ and H-4’); 1.71 (s, 3H, H-10’); 1.67 (s, 3H, H-8’); 1.61 (s, 3H, H-9’). 
13C-NMR: 143.0 (C-1), 147.6 (C-2), 98.2 (C-3), 151.4 (C-4), 121.9 (C-5), 
113.9 (C-6), 56.3 (OCH3), 56.7 (OCH3), 56.6 (OCH3), 27.6 (C-1’), 122.7 (C-
2’), 136.0 (C-3’), 39.8 (C-4’), 26.8 (C-5’), 124.3 (C-6’), 131.4 (C-7’), 25.7 
(C-8’), 17.7 (C-9’), 16.0 (C-10’). IR (cm-1): 2921, 1511, 1459, 1202,1037. MS 
(m/z, %): M+ 304 (100), 235 (36), 221 (20), 205 (22), 204 (52), 203 (13), 190 
(13), 189 (24), 182 (62), 69(11).
2-methoxy-5-((E)-3’,7’-dimethylocta-2’,6’-dienyl)-1,4-benzoquinone 5
To geranyl-4,5-dimethoxyphenol 2 (0.1416 g, 0.5 mmol) dissolved in 
20 mL acetonitrile/water (1:1), CAN (0.1725 g, 0.3 mmol) was added. The 
mixture was stirred at -5 ºC during 20 minutes. Dilution with diethyl ether 
was followed by washing with water and the organic phase was dried over 
anhydrous Na2SO4. The solution was evaporated to dryness to afford the crude 
reaction product, which gave 20 mg (15 % yield) of compound 5, after column 
chromatography (eluent to hexane/ethyl acetate 19.8:0.2→17.0:3.0), colorless 
viscous oil. 1H-NMR: 6.46 (t, 1H, H-6); 5.92 (s, 1H, H-3); 5.15 (t, J= 7.0 Hz, 
1H, H-2’); 5.07 (t, J= 7.0 Hz, 1H, H-6’); 3.81 (s, 3H, OCH3); 3.13 (d, J= 7.0, 
2H, H-1’); 2.07 (m, 4H, H-5’ and H-4’); 1.69 (s, 3H, H-10’); 1.61 (s, 3H, H-8’); 
1.60 (s, 3H, H-9’). 13C-NMR: 182.4 (C-1), 158.7 (C-2), 107.7 (C-3), 187.6 
(C-4), 149.6 (C-5), 130.3 (C-6), 56.2 (OCH3), 27.3 (C-1’), 117.8 (C-2’), 140.1 
(C-3’), 39.6 (C-4’), 26.4 (C-5’), 130.3 (C-6’), 131.9 (C-7’), 25.7 (C-8’), 17.7 
(C-9’), 16.1 (C-10’). IR (cm-1): 3018, 2929, 1675, 1651, 1606, 1458. MS (m/z, 
%): M+ 274 (< 1%), 247 (3), 221 (20), 205 (29), 168 (15), 167 (100), 166 (8), 
161 (6), 69 (11).
4,5-dimethoxy-2-((E)-3’,7’-dimethylocta-2’,6’-dienyl)phenyl acetate 6
To geranyl-4,5-dimethoxyphenol 2 (0.0367 g, 0.13 mmol) dissolved 
in dichloromethane (10 mL), acetic anhidric (0.01 g, 0.01 mL, 0.13 mmol) 
and dimethylaminopyridine (DMAP, 1.5 mg, 0.013 mmol) were added. The 
mixture was stirred at room temperature during 2 hours. The organic phase was 
washed with water and after it was dried over anhydrous Na2SO4. The solution 
was evaporated to dryness to afford the crude reaction product, which gave 
30 mg (70 % Yield) of compound 6 after column chromatography (eluent to 
hexane/ethyl acetate 19.8:0.2→17.0:3.0), colorless viscous oil. 1H-NMR: 6.70 
(s, 1H, H-6); 6.56 (s, 1H, H-3); 5.22 (t, J= 7.0 Hz, 1H, H-2’); 5.10 (t, J= 7.0 Hz, 
1H, H-6’); 3.84 (s, 3H, OCH3); 3.83 (s, 3H, OCH3); 3.17 (d, J= 7.0, 2H, H-1’); 
2.29 (s, 3H, CO2CH3); 2.07 (m, 4H, H-5’ and H-4’); 1.69 (s, 3H, H-10’); 1.67 
(s, 3H, H-8’); 1.59 (s, 3H, H-9’). 13C-NMR: 146.9 (C-1), 124.8 (C-2), 112.3 
(C-3), 141.8 (C-4), 147.5 (C-5), 106.1 (C-6), 56.0 (OCH3), 56.1 (OCH3), 28.2 
(C-1’), 121.8 (C-2’), 136.8 (C-3’), 39.7 (C-4’), 26.7 (C-5’), 124.1 (C-6’), 131.5 
(C-7’), 25.7 (C-8’), 17.7 (C-9’), 16.2 (C-10’), 20.8 (CO2CH3), 169.8 (CO2). IR 
(cm-1): 2922, 1764, 1658, 1620, 1513, 1205, 1174, 1014. MS (m/z, %): M+ 332 
(87), 291 (20), 290 (94), 221 (39), 207 (16), 189 (40), 175 (18), 168 (14), 167 
(100), 161 (52), 154 (13), 129 (20), 69 (18).
2,4,5-trimethoxyphenyl formate 8
To 2,4,5-trimethoxybenzaldehyde 7 (2.02 g, 10 mmol) dissolved in 
dichloromethane (70 mL), metachloroperoxibenzoic acid (MCPBA, 3.30 g, 19 
mmol) and sodium bicarbonate (1.82 g, 21 mmol) were added. The mixture 
was stirred at room temperature during 2 hours. The organic phase was washed 
with water (2 × 10 mL) and after it was dried over anhydrous Na2SO4. The 
solution was evaporated to dryness to afford the crude reaction product which 
gave 1.87 g (86 % Yield) of compound 8 after column chromatography (eluent 
to hexane/ethyl acetate 19.8:0.2→14,0:6,0), colorless viscous oil 1H-RMN: 
8.28 (s, 1H, CHO), 6.85 (s, 1H, H-6), 6.78 (s, 1H, H-3), 3.91 (s, 3H, OCH3), 
3.85 (s, 6H, OCH3). 
13C-RMN: 161.3 (CHO), 122.1 (C-6), 101.8 (C-3).
2,4,5-trimethoxyphenol 9
To 2,4,5-trimethoxyphenyl formate 8 (3.68 g, 17 mmol) dissolved in 
methanol (50 mL) triethylamine (4 mL) were added. The mixture was stirred 
at room temperature during 30 minutes. Then, the solution was evaporated to 
dryness. Dilution with EtOAc was followed by washing with HCl solution 
(5%) (2 × 10 mL) and the organic phase was dried over anhydrous Na2SO4. The 
solution was evaporated to dryness to afford the crude reaction product, which 
gave 2.45 g (78 % yield) of compound 9 after column chromatography (eluent 
to hexane/ethyl acetate 19.8:0.2→14,0:6,0), colorless viscous oil 1H-RMN: 
6.58 (s, 1H, H-6), 6.44 (s, 1H, H-3), 3.87 (s, 3H, OCH3), 3.84 (s, 6H, OCH3). 
13C-RMN: 104.8 (C-3), 100.1 (C-6).
Cell lines
The experimental cell lines MCF-7, MDA-MB-231 and PC-3 were 
obtained from American Type Culture Collection (Rockville, MD, USA). 
MCF-7, MDA-MB-231, PC-3 and DHF cells were grown in DMEM-F12 
containing 10% FCS, 100 U/ml penicillin, 100 µg/ml streptomycin and 1 mM 
glutamine at 37°C under a humidified 5% CO2. 
Cell growth inhibition assay
The colorimetric assay using sulforhodamine B (SRB) following an 
adaptation of the described method for Skehan25-26 was used. Cells were seeded 
in 96-well microtiter plates, at 5x103 cells per well in aliquots of 100 µL of 
medium, and they were allowed to attach to the plate surface by growing in 
drug-free medium for 18 h. Afterwards, compounds samples were added in 
aliquots to achieve a final concentration of 12.5, 25, 50 and 100 µM. Stock 
solution of compounds was prepared in ethanol and the final concentration of 
this solvent was kept constant at 1%. Control cultures received 1% ethanol 
alone. After 72 h exposure, the cytotoxicity was measured by the SRB dye 
assay. Cells were fixed by adding cold 50% (wt/vol) trichloroacetic acid (TCA, 
25 µL) and incubated for 60 min at 4 ºC. Plates were washed with deionized 
water and dried; SRB solution (0.1% wt/vol in 1% acetic acid, 50 µL) was 
added to each microtiter well and incubated for 30 min at room temperature. 
Unbound SRB was removed by washing with 1% acetic acid. Plates were air-
dried and bound stain was solubilized with Tris base (100 µL, 10 mM). Optical 
densities were read on an automated spectrophotometer plate reader at a single 
wavelength of 540 nm. Values shown are the % viability vs. Ctrl + SD, n=four 
independent experiments in triplicate.
Table 1. Cytotoxicity (IC50 µM +/- SD) of geranylmethoxyhydroquinone 
derivatives 1-6.
Compound PC-3 MCF-7 MDA-MB-231 DHF
1 > 100 82.2 +/- 6.5 > 100 > 100
2 > 100 > 100 > 100 > 100
3 > 100 > 100 > 100 > 100
4 > 100 > 100 > 100 > 100
5 > 100 84.2 +/- 8.9 86.2 +/- 7.1 > 100
6 > 100 > 100 > 100 > 100
Daunorubicin 0.36+/-0.12 0.19 +/- 0.11 0.32 +/- 0.09 1.34 +/- 0.31
CONCLUSIONS
In summary, we have prepared the new synthetic geranyl-2,4-
methoxyhydroquinone 1 and known geranyl-4,5-methoxyhydroquinone 
2. These compounds were obtained unexpectedly by Electrophilic 
Aromatic Substitution (EAS) coupling reactions between geraniol with 
2,4,5-trimethoxyphenol. Furthermore, the geranylmethoxyhydroquinone 
derivatives (3-6) were obtained of the chemical transformations of the 
compounds coupling 1 and 2. The compound 5 showed cytotoxic activity 
against cell line MCF-7 and MDA-MB-231 with IC50 values of 84.2 and 86.2 
µM respectively. The compound 1 showed some selectivity against cell line 
MCF-7 with an IC50 value of 82.2 µM. The increased citotoxicity induced by 
compounds 1 and 5 on cell lines can be probably due to the presence of a 
quinone moiety and position of the hydroxyl group on the structure of these 
compounds versus the compounds 2, 3, 4 and 6.
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